The latter has been correlated with a STING-low SCLC phenotype, resulting in increased expression of pro‐inflammatory chemokines and cytokines as well as genes encoding interferon type I signaling following dual inhibition of TOP1 and ATR [232]. The gene discussed is STING1; the disease is small cell lung carcinoma.